Report Detail
Global Octreotide Market Insights, Forecast to 2025
- RnM3036256 |
- 28 February, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug.
The Octreotide product increased fast in the past five years, the production growth in the past two years. There have been new manufacturers to enter the field year by year. But for now , it is difficult to obtain certification.
It will expect that the production and the capacity will increase fast in the future, But with octreotide acetate in China continues to mature in manufacturing technology, in the future, trade of octreotide API will gradually decrease, more and more Octreotide will sold as finished medicine.
The global Octreotide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Octreotide market based on company, product type, end user and key regions.
This report studies the global market size of Octreotide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Octreotide in these regions.
This research report categorizes the global Octreotide market by top players/brands, region, type and end user. This report also studies the global Octreotide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Market size by Product
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Market size by End User
Treating Severe Diarrhea
Treating Acromegaly
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Octreotide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Octreotide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Octreotide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Octreotide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Octreotide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Gram). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Octreotide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Octreotide Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Octreotide Market Size Growth Rate by Product
- 1.4.2 Octreotide Injection
- 1.4.3 Octreotide Powder
- 1.4.4 Octreotide Microspheres
- 1.5 Market by End User
- 1.5.1 Global Octreotide Market Size Growth Rate by End User
- 1.5.2 Treating Severe Diarrhea
- 1.5.3 Treating Acromegaly
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Octreotide Market Size
- 2.1.1 Global Octreotide Revenue 2014-2025
- 2.1.2 Global Octreotide Sales 2014-2025
- 2.2 Octreotide Growth Rate by Regions
- 2.2.1 Global Octreotide Sales by Regions
- 2.2.2 Global Octreotide Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Octreotide Sales by Manufacturers
- 3.1.1 Octreotide Sales by Manufacturers
- 3.1.2 Octreotide Sales Market Share by Manufacturers
- 3.1.3 Global Octreotide Market Concentration Ratio (CR5 and HHI)
- 3.2 Octreotide Revenue by Manufacturers
- 3.2.1 Octreotide Revenue by Manufacturers (2014-2019)
- 3.2.2 Octreotide Revenue Share by Manufacturers (2014-2019)
- 3.3 Octreotide Price by Manufacturers
- 3.4 Octreotide Manufacturing Base Distribution, Product Types
- 3.4.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Octreotide Product Type
- 3.4.3 Date of International Manufacturers Enter into Octreotide Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Octreotide Sales by Product
- 4.2 Global Octreotide Revenue by Product
- 4.3 Octreotide Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Octreotide Breakdown Data by End User
6 North America
- 6.1 North America Octreotide by Countries
- 6.1.1 North America Octreotide Sales by Countries
- 6.1.2 North America Octreotide Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Octreotide by Product
- 6.3 North America Octreotide by End User
7 Europe
- 7.1 Europe Octreotide by Countries
- 7.1.1 Europe Octreotide Sales by Countries
- 7.1.2 Europe Octreotide Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Octreotide by Product
- 7.3 Europe Octreotide by End User
8 Asia Pacific
- 8.1 Asia Pacific Octreotide by Countries
- 8.1.1 Asia Pacific Octreotide Sales by Countries
- 8.1.2 Asia Pacific Octreotide Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Octreotide by Product
- 8.3 Asia Pacific Octreotide by End User
9 Central & South America
- 9.1 Central & South America Octreotide by Countries
- 9.1.1 Central & South America Octreotide Sales by Countries
- 9.1.2 Central & South America Octreotide Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Octreotide by Product
- 9.3 Central & South America Octreotide by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Octreotide by Countries
- 10.1.1 Middle East and Africa Octreotide Sales by Countries
- 10.1.2 Middle East and Africa Octreotide Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Octreotide by Product
- 10.3 Middle East and Africa Octreotide by End User
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis Octreotide Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 Sun Pharmaceutical
- 11.2.1 Sun Pharmaceutical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sun Pharmaceutical Octreotide Products Offered
- 11.2.5 Sun Pharmaceutical Recent Development
- 11.3 Chengdu Tiantaishan pharmaceutical
- 11.3.1 Chengdu Tiantaishan pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
- 11.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
- 11.4 Sinopharm A-Think Pharmaceuticals
- 11.4.1 Sinopharm A-Think Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
- 11.4.5 Sinopharm A-Think Pharmaceuticals Recent Development
- 11.5 Sihuan Pharmaceutical Holdings Group
- 11.5.1 Sihuan Pharmaceutical Holdings Group Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
- 11.5.5 Sihuan Pharmaceutical Holdings Group Recent Development
- 11.6 Shanghai Soho-Yiming Pharmaceuticals
- 11.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
- 11.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
- 11.7 Yibin Pharmaceutical
- 11.7.1 Yibin Pharmaceutical Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Yibin Pharmaceutical Octreotide Products Offered
- 11.7.5 Yibin Pharmaceutical Recent Development
12 Future Forecast
- 12.1 Octreotide Market Forecast by Regions
- 12.1.1 Global Octreotide Sales Forecast by Regions 2019-2025
- 12.1.2 Global Octreotide Revenue Forecast by Regions 2019-2025
- 12.2 Octreotide Market Forecast by Product
- 12.2.1 Global Octreotide Sales Forecast by Product 2019-2025
- 12.2.2 Global Octreotide Revenue Forecast by Product 2019-2025
- 12.3 Octreotide Market Forecast by End User
- 12.4 North America Octreotide Forecast
- 12.5 Europe Octreotide Forecast
- 12.6 Asia Pacific Octreotide Forecast
- 12.7 Central & South America Octreotide Forecast
- 12.8 Middle East and Africa Octreotide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Octreotide Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Octreotide . Industry analysis & Market Report on Octreotide is a syndicated market report, published as Global Octreotide Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Octreotide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
